-Kafila.org Dear Prime Minister Modi ji, We, the undersigned, wish to share with you some of our concerns on India's position on intellectual property (IP), particularly in the context of bilateral relations between the United States of America and India. We gather from the US-India Joint Statement dated 30 September 2014 that the Indian Government (a)greeing on the need to foster innovation in a manner that promotes economic growth...

-Economic and Political Weekly The cultivation of geneticallymodified crops, especially food crops, is not just a domestic issue; it has an impact on global food trade as well. Sukhpal Singh (sukhpal@iimahd.ernet.in) is at the Centre for Management in Agriculture, IIM, Ahmedabad. There is no doubt that the application of Biotechnology can lead to yield improvement, cost cutting and lower crop losses, besides providing more processable raw materials and designer products. That is why...

-The Tribune AgBiotechnology is presented in many forms - the most common being that it will solve world hunger. To reinforce this claim, there is an interesting word play at work. AgBiotechnology is referred to as the ‘Evergreen Revolution' or the 'Gene Revolution' but never genetic engineering, which is its correct name. Both Evergreen Revolution and Gene Revolution are deliberately coined terms which attempt to link Agbiotech with the Green Revolution....

-Press Information Bureau The Ministry of Women and Child Development has fast tracked the formulation of the National Mission to tackle mal-nutrition. This Mission is now the flagship programme of the Ministry and is very high on the national agenda of the government. In order to formulate the detailed contours of the Mission and to examine innovative interventions which can be put into place to tackle the problem of malnutrition, a...

-The Business Standard A ray of hope for Indian generic drug makers Gilead Sciences, the California-headquartered Biotechnology company, has authorised seven India-based drug makers - Cipla, Ranbaxy, Mylan, Strides Arcolab, Hetero, Cadila Healthcare and Sequent Scientific - to manufacture and sell the generic versions of its hepatitis C medicine, Sovaldi, in 91 developing countries. Earlier in the week, Lupin, the fourth largest Indian drug maker, announced that it will develop and supply...